Latest Shareholder Participation News

CONNEQT Health Limited is offering eligible shareholders a share purchase plan to raise up to $0.5 million at a 24.3% discount, aiming to fund its next growth phase in vascular health technology.

Strategic Energy Resources (ASX:SER) has raised $1.5 million through a discounted share placement and a fully underwritten share purchase plan to back a high-impact drilling campaign at its Diamantina Copper-Gold Project in Queensland.

Kingston Resources launches a $8.47 million rights issue at a 12.5% discount, backed by a $4.4 million placement, to finance a major drilling campaign and plant expansion at Mineral Hill following the closure of its Pearse South open pit.

TZ Limited (ASX:TZL) has launched a 1-for-4 non-renounceable entitlement offer priced at 3 cents per share, aiming to raise approximately $2.58 million to reduce debt and fund growth initiatives.

Constellation Resources is raising $3.22 million through a non-renounceable entitlement offer priced at $0.12 per share, aiming to bolster exploration in Western Australia and support general working capital.

Kingfish Limited posted a $13.6 million net loss for the year ended 31 March 2026, with portfolio returns lagging the benchmark amid geopolitical tensions and AI sector uncertainty.

Beonic Ltd has closed its 5-for-9 renounceable entitlement offer, raising $1.58 million before costs, surpassing initial uptake expectations and reducing underwriting obligations.

ClearVue Technologies has secured A$6 million through a $5 million institutional placement and a fully underwritten $1 million Share Purchase Plan, aiming to bolster its balance sheet and fund international expansion and product development.

CONNEQT Health has raised A$5.5 million through a two-tranche placement at a 15.4% discount, backed by key shareholders, to accelerate its commercial expansion and product development.

Vitrafy Life Sciences has launched a non-underwritten Share Purchase Plan to raise approximately A$2 million, offering existing Australian and New Zealand shareholders the chance to buy shares at A$2.60 each, matching the recent institutional placement price.

Finder Energy has issued 12 million shares at 50 cents each, raising $6 million from Amplus Energy and Longreach Capital following shareholder approval.

Vitrafy Life Sciences has secured A$30 million through an institutional placement to ramp up manufacturing of its Guardion cryopreservation devices and expand US sales operations, with an additional A$2 million sought via a shareholder plan.